Français
ItalianoBond Amgen 4.563% ( US031162CD02 ) in USD
| Issuer | Amgen | ||||||||||||||||||||||||||||||||||||||||
| Market price |  96.97 % ▲ |
||||||||||||||||||||||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||||||||||||||||||||||
| ISIN code |
 US031162CD02 ( in USD )
|
||||||||||||||||||||||||||||||||||||||||
| Interest rate | 4.563% per year ( payment 2 times a year) | ||||||||||||||||||||||||||||||||||||||||
| Maturity | 15/06/2048 | ||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||||||||||||||||||||||
| Total amount | 1 415 205 000 USD | ||||||||||||||||||||||||||||||||||||||||
| Cusip | 031162CD0 | ||||||||||||||||||||||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||||||||||
| Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||||||||||||||||||||||
| Next Coupon | 15/12/2026 ( In 92 days ) | ||||||||||||||||||||||||||||||||||||||||
| Detailed description |
Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162CD02, pays a coupon of 4.563% per year. The coupons are paid 2 times per year and the Bond maturity is 15/06/2048 The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162CD02, was rated Baa1 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162CD02, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
